Amplia Therapeutics Ltd (ASX: ATX) Share Price and News
Price
Movement
52 Week Range
1 Year Return
() Chart and Price Data
Fundamental Company Figures
Data provided by Morningstar.Amplia Therapeutics Ltd (ASX: ATX) Latest News
Here’s why the Amplia (ASX:ATX) share price is up 9% today
Aaron Teboneras | February 17, 2021 1:19pm
Amplia Therapeutics share price up 16% in 2 days as former Macquarie CEO takes substantial stake
Chris Chitty | July 15, 2020 2:04pm
US congressman resigns over ASX insider trading penny stock scandal
Tom Richardson | October 1, 2019 12:57pm
ASX Watergate Arrest: The alleged insider trading at Innate Immunotherapeutics Ltd (ASX:IIL)
Sean O'Neill | August 9, 2018 1:10pm
Cann Group Ltd is one of 64 new shares added to the All Ordinaries this quarter
James Mickleboro | March 9, 2018 10:05am
Were these the 3 worst shares on the ASX in 2017?
James Mickleboro | December 29, 2017 2:40pm
These are the 5 biggest losers on the All Ordinaries in the last 12 months
James Mickleboro | August 17, 2017 1:31pm
One crucial thing to consider before investing in risky biotech shares
Sean O'Neill | August 10, 2017 3:53pm
Recent Stock Announcements
Date | Heading | An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. | Time | Pages | File Size |
---|---|---|---|---|---|
About Amplia Therapeutics Ltd (ASX: ATX)
Amplia Therapeutics Ltd is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. Its molecule, AMP945 is a pure play inhibitor, while the second molecule, AMP886, is a multi-action molecule that hits two other important cancer pathways - VEGFR3 and FLT3.
Share Price History
Data provided by Morningstar.Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
26 Feb 2021 | $0.28 | $-0.01 | -3.57% | 222,273 | $0.28 | $0.28 | $0.26 |
25 Feb 2021 | $0.28 | $0.01 | 3.70% | 57,734 | $0.27 | $0.28 | $0.27 |
24 Feb 2021 | $0.27 | $-0.01 | -3.64% | 1,789 | $0.27 | $0.27 | $0.27 |
23 Feb 2021 | $0.28 | $0.00 | 0.00% | 39,962 | $0.28 | $0.28 | $0.28 |
22 Feb 2021 | $0.28 | $-0.01 | -3.51% | 127,876 | $0.29 | $0.29 | $0.27 |
19 Feb 2021 | $0.29 | $0.00 | 0.00% | 56,590 | $0.29 | $0.29 | $0.28 |
17 Feb 2021 | $0.29 | $0.02 | 7.41% | 371,454 | $0.29 | $0.30 | $0.29 |
16 Feb 2021 | $0.27 | $-0.01 | -3.57% | 77,472 | $0.29 | $0.29 | $0.27 |
15 Feb 2021 | $0.28 | $0.01 | 3.70% | 52,000 | $0.28 | $0.29 | $0.28 |
12 Feb 2021 | $0.27 | $-0.01 | -3.64% | 18,687 | $0.27 | $0.27 | $0.27 |
11 Feb 2021 | $0.28 | $0.01 | 3.70% | 150,721 | $0.27 | $0.29 | $0.27 |
10 Feb 2021 | $0.27 | $0.00 | 0.00% | 48,233 | $0.27 | $0.27 | $0.27 |
09 Feb 2021 | $0.27 | $-0.01 | -3.64% | 78,673 | $0.28 | $0.28 | $0.27 |
08 Feb 2021 | $0.28 | $0.01 | 3.70% | 109,568 | $0.27 | $0.28 | $0.26 |
05 Feb 2021 | $0.27 | $0.01 | 3.85% | 178,098 | $0.27 | $0.27 | $0.26 |
04 Feb 2021 | $0.26 | $-0.01 | -3.70% | 88,785 | $0.26 | $0.27 | $0.26 |
03 Feb 2021 | $0.27 | $0.01 | 3.85% | 156,745 | $0.26 | $0.27 | $0.26 |
02 Feb 2021 | $0.26 | $0.00 | 0.00% | 67,398 | $0.26 | $0.26 | $0.26 |
01 Feb 2021 | $0.26 | $-0.01 | -3.77% | 187,639 | $0.27 | $0.27 | $0.26 |
29 Jan 2021 | $0.27 | $-0.01 | -3.70% | 122,313 | $0.27 | $0.28 | $0.27 |
28 Jan 2021 | $0.27 | $-0.03 | -10.17% | 391,247 | $0.29 | $0.29 | $0.27 |
Director Transactions
Data provided by Morningstar.Directors & Management
Data provided by Morningstar.Top Share Holders
Data provided by Morningstar.Name | Shares | Capital |
---|---|---|
HSBC Custody Nominees (Australia) Limited | 17,398,080 | 20.15% |
Bond Street Custodians Limited <LAM1 - D08047 A/C> | 7,500,000 | 8.69% |
Citicorp Nominees Pty Limited | 7,397,724 | 8.57% |
CTXT Pty Ltd | 4,514,468 | 5.23% |
Elk River Holdings Pty Ltd | 2,942,142 | 3.41% |
Christopher John Burns | 2,275,237 | 2.64% |
34th Avenue Pty Ltd <Devlin Family A/C> | 2,215,237 | 2.57% |
Warwick Tong | 1,941,428 | 2.25% |
Mark Sullivan <AEMS Consulting A/C> | 1,661,428 | 1.92% |
Merrill Lynch (Australia) Nominees Pty Limited | 1,534,712 | 1.78% |
Cancer Research Technology Limited | 1,360,524 | 1.58% |
Cofactor LLC | 1,000,000 | 1.16% |
HWH Power Pty Ltd <HWH Super Fund A/C> | 950,000 | 1.10% |
Margaret Frame | 923,016 | 1.07% |
Calama Holdings Pty Ltd <Mambat Super Fund A/C> | 875,000 | 1.01% |
Symington Pty Ltd | 710,000 | 0.82% |
Mr Andrew Podolak | 610,000 | 0.71% |
Yelwac Pty Ltd <The Cawley Superfund No2 A/C> | 600,000 | 0.69% |
Mr Li Sun | 580,000 | 0.67% |
Mrs Patricia Watkins + Mr John Phibbs + Mr Graeme Halse | 566,625 | 0.66% |